The Canadian Cancer Society’s Disruptive Innovation Grants will be bold, high-risk/high-reward, early-stage projects for maximum impact. The Lundin Cancer Fund is partnering to ensure at least one glioblastoma project is funded through the Disruptive Innovation Grants. Learn more
The Lundin Cancer Fund will aim to fully fund a four-year glioblastoma clinical trial at the Lundin Family Brain Tumour Research Centre at the Lausanne University Hospital (CHUV) where Lukas Lundin was treated. CHUV is a world leader in brain cancer research. Learn more